跳至主要内容
临床试验/EUCTR2011-001943-60-DK
EUCTR2011-001943-60-DK进行中(未招募)1 期

Cellular immunity in adult Hepatitis B-vaccinated serologic non-responders - CMI HBV vacc

ars Jørgen Østergaard0 个研究点目标入组 400 人开始时间: 2011年6月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Written informed consent and authority statement provided according
  • to local regulatory and ethical practice using a participant information
  • sheet and informed consent form approved by the responsible Ethics Committee.
  • 2) Male or female participants = 18 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 400
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Allergy to formaldehyde (contained in Twinrix)
  • 2) Former HBV immunization
  • 3) Former HBV infection
  • 4) Known chronic HBV infection
  • 5) Participants unwilling to use reliable contraception for the duration of the trial (if female). Reliable methods of birth control include:
  • pharmacologic contraceptives including oral, parenteral and transdermal
  • delivery, surgical sterilization, vaginal ring, intrauterine device,
  • abstinence and post-menopause (if female).
  • 6) Pregnancy or wish of pregnancy within six months after time of study inclusion.

研究者

发起方
ars Jørgen Østergaard

相似试验